Found: 16
Select item for more details and to access through your institution.
Glycoprotein-Specific Polyclonal Antibodies Targeting Machupo Virus Protect Guinea Pigs against Lethal Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 674, doi. 10.3390/vaccines12060674
- By:
- Publication type:
- Article
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 497, doi. 10.3390/vaccines12050497
- By:
- Publication type:
- Article
SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071104
- By:
- Publication type:
- Article
Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA vaccine in rhesus macaques (Macaca mulatta) delivered using needle-free jet injection.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0275082
- By:
- Publication type:
- Article
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0137786
- By:
- Publication type:
- Article
Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65059-0
- By:
- Publication type:
- Article
DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 264, p. 1, doi. 10.1126/scitranslmed.3010082
- By:
- Publication type:
- Article
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.81743
- By:
- Publication type:
- Article
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 4, p. 888, doi. 10.1093/cid/ciae215
- By:
- Publication type:
- Article
A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challenge.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00469-x
- By:
- Publication type:
- Article
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-020-00279-z
- By:
- Publication type:
- Article
Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216700
- By:
- Publication type:
- Article
Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models.
- Published in:
- Frontiers in Microbiology, 2020, v. 11, p. 1, doi. 10.3389/fmicb.2020.00832
- By:
- Publication type:
- Article